Caspase-dependent apoptosis in Riboflavin Transporter Deficiency iPSCs and derived motor neurons
Chiara MarioliMaurizio MuzziFiorella ColasuonnoCristian FiorucciNicolò CicolaniStefania PetriniEnrico BertiniMarco TartagliaClaudia CompagnucciSandra MorenoPublished in: Cell death discovery (2024)
Riboflavin Transporter Deficiency (RTD) is a rare genetic, childhood-onset disease. This pathology has a relevant neurological involvement, being characterized by motor symptoms, ponto-bulbar paralysis and sensorineural deafness. Such clinical presentation is associated with muscle weakness and motor neuron (MN) degeneration, so that RTD is considered part of the MN disease spectrum. Based on previous findings demonstrating energy dysmetabolism and mitochondrial impairment in RTD induced Pluripotent Stem cells (iPSCs) and iPSC-derived MNs, here we address the involvement of intrinsic apoptotic pathways in disease pathogenesis using these patient-specific in vitro models by combined ultrastructural and confocal analyses. We show impaired neuronal survival of RTD iPSCs and MNs. Focused Ion Beam/Scanning Electron Microscopy (FIB/SEM) documents severe alterations in patients' cells, including deranged mitochondrial ultrastructure, and altered plasma membrane and nuclear organization. Occurrence of aberrantly activated apoptosis is confirmed by immunofluorescence and TUNEL assays. Overall, our work provides evidence of a role played by mitochondrial dysfunction in RTD, and identifies neuronal apoptosis as a contributing event in disease pathogenesis, indicating intrinsic apoptosis pathways as possible relevant targets for more effective therapeutical approaches.
Keyphrases
- cell cycle arrest
- electron microscopy
- oxidative stress
- cell death
- induced pluripotent stem cells
- endoplasmic reticulum stress
- induced apoptosis
- pi k akt
- genome wide
- risk assessment
- newly diagnosed
- gene expression
- ejection fraction
- high resolution
- dna methylation
- early onset
- signaling pathway
- physical activity
- copy number
- depressive symptoms
- replacement therapy
- blood brain barrier
- drug induced
- liver fibrosis
- anti inflammatory
- chronic kidney disease
- patient reported
- myasthenia gravis